Literature DB >> 27702930

Triple threat in pregnancy.

Swati Vishwanathan1, Michael Lucke2, Indu G Poornima3.   

Abstract

A woman aged 22 years with a history of lupus presented in the 18th week of pregnancy with hypertensive emergency and flash pulmonary oedema. Bedside echocardiogram revealed severe left ventricular (LV) dysfunction with an ejection fraction (EF) of 25% and pericardial effusion. Laboratories revealed hypocomplementemia, proteinuria, elevated C reactive protein and anti-DS-DNA, raising concern for a lupus flare. Cardiac MRI showed an acute intramyocardial oedematous process, consistent with lupus carditis, and further worsening of LVEF to 13%. Shared-decision-making with the patient included discussion of maternal risks of continuation of pregnancy in the setting of worsening heart function and the fetal risks of definitive treatment with cyclophosphamide for a lupus flare and the patient decided to proceed with medical termination of pregnancy. Treatment with immunosuppressants, including cyclophosphamide, and steroids, was then initiated. 2 months after discharge, cardiac MRI showed marked improvement in LVEF to 50% and the patient remains clinically free of heart failure. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27702930      PMCID: PMC5073724          DOI: 10.1136/bcr-2016-216385

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

Review 1.  Intravenous immunoglobulin therapy and systemic lupus erythematosus.

Authors:  Gisele Zandman-Goddard; Yair Levy; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

2.  Intravenous immunoglobulin therapy in severe lupus myocarditis: good outcome in three patients.

Authors:  D Micheloud; M Calderón; M Caparrros; D P D'Cruz
Journal:  Ann Rheum Dis       Date:  2007-07       Impact factor: 19.103

Review 3.  Effects of immunosuppressive drugs during pregnancy.

Authors:  B L Bermas; J A Hill
Journal:  Arthritis Rheum       Date:  1995-12

Review 4.  Myocarditis in systemic lupus erythematosus.

Authors:  Mevan Wijetunga; Stanley Rockson
Journal:  Am J Med       Date:  2002-10-01       Impact factor: 4.965

Review 5.  Cardiac involvement in systemic lupus erythematosus.

Authors:  A Doria; L Iaccarino; P Sarzi-Puttini; F Atzeni; M Turriel; M Petri
Journal:  Lupus       Date:  2005       Impact factor: 2.911

6.  Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience.

Authors:  M Petri; D Howard; J Repke
Journal:  Arthritis Rheum       Date:  1991-12

Review 7.  Cardiac involvement in systemic lupus erythematosus.

Authors:  K G Moder; T D Miller; H D Tazelaar
Journal:  Mayo Clin Proc       Date:  1999-03       Impact factor: 7.616

8.  Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study.

Authors:  Jill P Buyon; Mimi Y Kim; Marta M Guerra; Carl A Laskin; Michelle Petri; Michael D Lockshin; Lisa Sammaritano; D Ware Branch; T Flint Porter; Allen Sawitzke; Joan T Merrill; Mary D Stephenson; Elisabeth Cohn; Lamya Garabet; Jane E Salmon
Journal:  Ann Intern Med       Date:  2015-08-04       Impact factor: 25.391

9.  A national study of the complications of lupus in pregnancy.

Authors:  Megan E B Clowse; Margaret Jamison; Evan Myers; Andra H James
Journal:  Am J Obstet Gynecol       Date:  2008-05-05       Impact factor: 8.661

10.  Associated factors and impact of myocarditis in patients with SLE from LUMINA, a multiethnic US cohort (LV). [corrected].

Authors:  M Apte; G McGwin; L M Vilá; R A Kaslow; G S Alarcón; J D Reveille
Journal:  Rheumatology (Oxford)       Date:  2008-02-04       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.